---
title: testing
layout: default
tags: advanced
category: oropharynx
---

<table class="table">
    <tbody>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Study title</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Elective versus Therapeutic Neck Dissection in
                    Node-Negative Oral Cancer
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>journal</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    New England Journal of Medicine
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>study year</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    2015
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>QUESTION</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Is there a survival difference between elective neck
                    dissection (END) and therapeutic neck dissection (TND)?
                </p>
                <p>
                    Does ultrasonography have a role in early detection of
                    nodal metastases during follow-up?
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Study DESIGN</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Prospective randomized controlled trial
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>STUDY GROUPS</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    END (ipsilateral neck dissection at the time of primary
                    surgery) (n=245) vs TND (watchful waiting followed by neck
                    dissection for nodal relapse) (n=255)
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Population</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Patients with lateralized stage T1-T2 oral squamous cell
                    carcinoma (OCSCC)
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Inclusion criteria</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    18-75 years old
                </p>
                <p>
                    Histopathologically proven invasive T1-T2 SCC of the oral
                    cavity lateralized to one side of the midline
                </p>
                <p>
                    No previous treatment Amenable to undergoing oral excision
                </p>
                <p>
                    No history of head and neck cancer
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Exclusion criteria</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Previous surgery in head and neck
                </p>
                <p>
                    Upper alveolar/palatal lesions
                </p>
                <p>
                    Large heterogeneous leukoplakias
                </p>
                <p>
                    Diffuse oral submucous fibrosis
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Follow-up</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    39 months
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Primary endpoint(s)</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Overall survival: END 80% (95% CI 74.1 – 85.8) vs TND 67.5%
                    (95%CI 61.0 – 73.9). Hazard ratio = 0.64 in END group
                    (p=0.01)
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Secondary endpoint(s)</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    Disease-free survival: END 69.5% vs TND 45.9%
                    (p&lt;0.001)&gt; Hazard ratio = 0.45 in END group
                    (p&lt;0.001)
                </p>
                <p>
                    Adverse events: END 6.6% vs TND 3.6%
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Weblink</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    https://www.nejm.org/doi/full/10.1056/nejmoa1506007
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Brief summary</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    In early OCSCC, END resulted in higher overall and
                    disease-free survival than TND
                </p>
            </td>
        </tr>
        <tr>
            <td width="131" valign="top">
                <p>
                    <strong>Authors</strong>
                </p>
            </td>
            <td width="294" valign="top">
                <p>
                    D’Cruz et al
                </p>
                <p>
                    Head and Neck Disease management Group, Mumbai, India
                </p>
            </td>
        </tr>
    </tbody>
</table>
